title: Minor histocompatibility antigen-specific T cells with multiple distinct specificities can be isolated by direct cloning of IFNgamma-secreting T cells from patients with relapsed leukemia responding to donor lymphocyte infusion.
abstract: Graft-vs-leukemia reactivity after donor lymphocyte infusion (DLI) can be mediated by donor T cells recognizing minor histocompatibility antigens (mHags) on recipient hematopoietic cells. To study the diversity of cells involved in this immune response, hematopoietic cell reactive T cells were directly clonally isolated from peripheral blood of patients entering complete remission after DLI. T cells were briefly stimulated with bone marrow cells from patients pretransplant, and IFNgamma-secreting T cells were directly clonally isolated, and expanded. Cytotoxic T-lymphocyte (CTL) clones from individual patients used multiple distinct HLA-restricting molecules and varied in reactivity against patient-derived normal and/or malignant hematopoietic cells. For each patient, CTL clones specific for known immunodominant mHags as well as distinct unknown mHags were found. Within individual patients, CTL clones using the same HLA-restricting element could show differential recognition patterns, indicating further diversity in mHag reactivity. CTL clones from individual patients exhibiting identical specificities could show oligoclonal origin. In conclusion, the direct cloning technique shows that the response to hematopoietic cells after DLI is directed against multiple distinct mHags, including but not limited to known immunodominant mHags, implying that immunotherapy with T cells against multiple mHag specificities may be more effective in eradicating malignant cells.
authors.affiliation: Department of Hematology, Leiden University Medical Center, C2-R, PO Box 9600, 2300 RC Leiden, The Netherlands. F.M.Kloosterboer@lumc.nl
authors.forename: F M
authors.initials: FM
authors.lastname: Kloosterboer
authors.forename: S A P
authors.initials: SA
authors.lastname: van Luxemburg-Heijs
authors.forename: R A
authors.initials: RA
authors.lastname: van Soest
authors.forename: H M
authors.initials: HM
authors.lastname: van Egmond
authors.forename: A M
authors.initials: AM
authors.lastname: Barbui
authors.forename: M P W
authors.initials: MP
authors.lastname: Strijbosch
authors.forename: R
authors.initials: R
authors.lastname: Willemze
authors.forename: J H F
authors.initials: JH
authors.lastname: Falkenburg
mesh_terms: D017690:Cell Transplantation; D005500:Follow-Up Studies; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism*; D008285:Major Histocompatibility Complex; D012008:Recurrence; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism / Q000637:transplantation
chemical_list: D007371:Interferon-gamma